A NEW HOPE FOR BODY CONTROL ?

Experts are excitedly focused on retatrutide, a promising medication created by Eli Lilly, as a potential advance in weight management. Unlike many earlier approaches, retatrutide is a twin-action agonist targeting equally GLP-1 and GIP, hormones that impact appetite and blood sugar control . Ea